Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,438,038
+$2,703,906 QoQ
Shares Held
1,485,803
+316.8% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 154 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Derivatives in FULC
reported options exposure · as of Mar 31, 2022CallValue
$827,750
CallShares
35,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. FULC ranks #162 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in FULC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,438,038 | 1,485,803 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,734,132 | 356,471 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $615,614 | 54,431 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,387,976 | 150,867 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $727,167 | 105,693 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $117,192 | 40,692 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $357,778 | 76,123 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $83,877 | 23,495 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,497,043 | 402,749 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,472,031 | 897,461 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,953,145 | 437,503 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,460,788 | 1,004,682 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,897,028 | 574,857 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,768,593 | 620,559 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $397,865 | 81,197 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $827,750 | 35,000 | Call | Sole | 2022-05-16 | |
| 2021-12-31 | $284,809 | 16,100 | Put | Sole | 2022-02-14 | |
| 2021-12-31 | $1,032,653 | 58,375 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,812,734 | 99,707 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,556,654 | 625,635 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,009,818 | 595,061 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $455,074 | 38,862 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $858,660 | 46,947 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,209,126 | 185,019 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||